These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8788859)

  • 1. Basolateral amygdala lesions do not disrupt latent inhibition.
    Weiner I; Tarrasch R; Feldon J
    Behav Brain Res; 1995 Dec; 72(1-2):73-81. PubMed ID: 8788859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity.
    Weiner I; Gal G; Rawlins JN; Feldon J
    Behav Brain Res; 1996 Nov; 81(1-2):123-33. PubMed ID: 8950008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the new antipsychotic, sertindole, on latent inhibition in rats.
    Weiner I; Kidron R; Tarrasch R; Arnt J; Feldon J
    Behav Pharmacol; 1994 Apr; 5(2):119-124. PubMed ID: 11224259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat.
    Lacroix L; Broersen LM; Weiner I; Feldon J
    Neuroscience; 1998 May; 84(2):431-42. PubMed ID: 9539214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
    Ruob C; Elsner J; Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition in rats.
    Schiller D; Weiner I
    Neuroscience; 2004; 128(1):15-25. PubMed ID: 15450350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus.
    Weiner I; Bernasconi E; Broersen LM; Feldon J
    Behav Pharmacol; 1997 Oct; 8(5):442-57. PubMed ID: 9832983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning.
    Schauz C; Koch M
    Learn Mem; 2000; 7(6):393-9. PubMed ID: 11112798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
    Weiner I; Izraeli-Telerant A; Feldon J
    Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
    Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
    Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of latent inhibition by chronic mild stress in rats submitted to emotional response conditioning.
    Melo LL; Ferrari EA; Teixeira NA; Sandner G
    Neural Plast; 2003; 10(4):327-33. PubMed ID: 15152986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
    Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The switching model of latent inhibition: an update of neural substrates.
    Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):11-25. PubMed ID: 9401704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
    Weiner I; Feldon J
    Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.
    Ruob C; Weiner I; Feldon J
    Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
    Zuckerman L; Rimmerman N; Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):298-307. PubMed ID: 12827344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.
    Joseph MH; Peters SL; Gray JA
    Psychopharmacology (Berl); 1993; 110(1-2):187-92. PubMed ID: 7870882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.